Photo Release: GSK Medicine Bank helps flood victims

Press Releases »

Bangkok--3 Oct--GSK Medicine Bank

Gen Pichate Wisaijorn (5th from left), Assistant Commander-in-Chief, Royal Thai Army and Mr Daniel Pruce (4th from left), Deputy Head of Mission, The British Embassy presided over the presentation of medicines to the Army Disaster Relief Center, Royal Thai Army at the meeting room, Royal Thai Army Headquarters. The GSK Medicine Bank represented by Mr Viriya Chongphaisal, (3rd from left), General Manager, GlaxoSmithKline (Thailand) Ltd. (GSK) presented the medicines to Lt Gen Phanuvich Pumhirun and Col Attawut Jansupareuk to help flood victims across the country and underprivileged people in the three southern border provinces. The ceremony was witnessed by AM Nitaya Imanotai. This activation reinforces GSK’s Access to Medicine program that is intended to encourage all people to have easier access to quality medicines and medical products Click for photo release at www.thaipr.net

ข่าวGlaxoSmithKline+o:healวันนี้

Marija Krstic Appointed as General Manager for GSK Thailand

GSK, a global biopharmaceutical company, has officially named Marija Krstic as the new General Manager of GlaxoSmithKline (Thailand) Co., Ltd. Ms. Krstic, who previously served as the Vaccine Market Lead for GSK's Growth Emerging Markets, will assume her new role, replacing Mr. Viriya Chongphaisal, starting on December 1, 2023. Marija, who has been with GSK since 2004, brings over two decades of expertise gained through her work in several countries. In her new role, she will play a pivotal part

Cipla ได้รับการอนุมัติขั้นสุดท้าย เพื่อวางจำหน่าย Sumatriptan Nasal Spray, 20 mg ยาสามัญที่มีต้นแบบจาก IMITREX(R) ของ GlaxoSmithKline

Cipla Limited (BSE: 500087) (NSE: CIPLA EQ) (ในที่นี้เรียกว่า "Cipla") ประกาศในวันนี้ว่า บริษัทได้รับการอนุมัติขั้นสุดท้ายหลังจากที่ได้ยื่นขึ้นทะเบียนยาใหม่...

Cipla receives final approval for generic version of GlaxoSmithKline's IMITREX(R) (Sumatriptan Nasal Spray, 20 mg)

Cipla Limited (BSE: 500087) (NSE: CIPLA EQ) (hereinafter referred to as "Cipla") today announced that it has received final approval for its Abbreviated New Drug Application (ANDA) for...

ViiV Healthcare Announces Positive New Dolutegravir Data for the Treatment of People Living With HIV Co-Infected With Tuberculosis

INSPIRING study results contribute to the extensive body of evidence for dolutegravir, the leading integrase strand transfer inhibitor, in diverse and hard to treat...

GSK's Global HIV Business ViiV Healthcare Completes Transactions to Acquire Bristol-Myers Squibb's R&D HIV Assets

GlaxoSmithKline plc (LSE: GSK) today announced that ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer Inc. and Shionogi Limited as shareholders, has...

Photo Release: GSK receives award for Good Corporate Governance 2014

Mr. Viriya Chongphaisal (Left), General Manager of GlaxoSmithKline Thailand (GSK), a leading pharmaceutical research and development company, receives the “Good Corporate Governance 2014” award from Mr.Panthep Klanarongran (Right)....

มอบชุดของขวัญ รักลูก New Mom Greeting 2011

ต้อนรับเทศกาลวันแม่ นิตยสารรักลูก ร่วมกับ 100 โรงพยาบาลชั้นนำทั่วประเทศ ส่งมอบชุดของขวัญสุดพิเศษสำหรับแม่คลอดบุตรใหม่ทั่วประเทศ ในโครงการ รักลูก New Mom Greeting 2011(ปี3) โดยมีผลิตภัณฑ์คุณภาพ ได้แก่ Dettol, B&B, Q-all และ GlaxoSmithKline...

Boehringer Ingelheim and GlaxoSmithKline Back EFA's Call for Urgent Improvements in Care for People With Lung Disease This World COPD Day

Boehringer Ingelheim and GSK, companies with a strong heritage in COPD (chronic obstructive pulmonary disease) and a commitment to improved patient care, have...